Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS
· Delayed Price · Currency is USD
35.25
0.00 (0.00%)
At close: Dec 3, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $12.54 billion as of December 5, 2025. Its market cap has increased by 30.75% in one year.
Market Cap
12.54B
Enterprise Value
13.87B
Revenue
2.96B
Ranking
n/a
PE Ratio
9,086.81
Stock Price
$35.25
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 12.54B, an increase of 1,790.76%. That is a compound annual growth rate of 16.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 298.99M |
| Nika Pharmaceuticals | 259.91M |